Features Screener Stocks Charts
Sign In Sign Up

Granules Financial Statements

NSE: GRANULES | BSE: 532482 | PHARMACEUTICALS

Showing 5 of 10 years of data. Sign up free for the full 10 years of history.

View Plans

Granules (GRANULES) reported revenue of ₹44.95B in FY2025 with net income of ₹5.02B. Total assets stood at ₹62.53B and free cash flow was ₹2.95B.

Granules Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025
Item Chart 2021 2022 2023 2024 2025
Revenue 32.38B 37.83B 45.26B 45.11B 44.95B
Cost of Rev. -13.91B -18.84B -23.07B -20.21B -17.26B
Gross Profit 18.46B 18.99B 22.18B 24.90B 27.69B
SGA -9.91B -11.59B -12.91B -16.29B -18.11B
Op. Income 7.04B 5.81B 7.43B 6.53B 7.33B
PBT 7.04B 5.58B 6.87B 5.47B 6.60B
Net Income 5.49B 4.13B 5.17B 4.05B 5.02B
Dil. Shares 249.19M 248.61M 245.74M 242.35M 242.50M
Diluted EPS 22.05 16.60 21.00 16.72 20.68

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Granules's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Granules Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025
Item Chart 2021 2022 2023 2024 2025
Curr. assets 19.97B 25.05B 25.74B 29.05B 31.15B
Non-curr. assets 17.16B 20.08B 23.30B 26.16B 31.37B
Total assets 37.13B 45.13B 49.05B 55.21B 62.53B
Curr. liabilities 11.73B 16.42B 18.14B 20.82B 20.03B
Non-curr. liab. 3.67B 2.84B 2.56B 2.13B 5.34B
Total liabilities 15.40B 19.26B 20.70B 22.95B 25.37B
Total equity 21.73B 25.87B 28.35B 32.26B 37.16B
Total liab. & eq. 37.13B 45.13B 49.05B 55.21B 62.53B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Granules's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Granules Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025
Item Chart 2021 2022 2023 2024 2025
Net Income 7.04B 5.58B 6.87B 5.47B 6.60B
Operating CF 4.32B 3.32B 7.39B 4.39B 8.67B
Capex -2.71B -3.98B -4.11B -3.81B -5.72B
Investing CF -2.77B -3.80B -1.91B -3.60B -6.91B
Dividend Paid -247.21M -371.71M -186.22M -363.06M -363.55M
Financing CF -2.99B 1.90B -4.40B 76.64M -925.06M
Cash (start) 1.86B 418.36M 1.85B 2.92B 3.81B
Cash (end) 418.36M 1.85B 2.92B 3.81B 4.66B
FCF 1.61B -656.51M 3.28B 588.38M 2.95B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Granules's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025

Related Stocks